Categorie - Updates

OBJECTIVEMetformin is the most common treatment for type 2 diabetes (T2D). However, there have been no pharmacogenomic...

OBJECTIVETo investigate the association between duration of type 2 diabetes and cancer incidence.RESEARCH DESIGN AND...

OBJECTIVETo examine the associations between age at type 2 diabetes diagnosis and the relative and absolute risk of all...

OBJECTIVEWe evaluated the safety and efficacy of fully closed-loop with ultrarapid insulin lispro in adults with type 1...

OBJECTIVERather than during illness while diabetic ketoacidosis (DKA) is developing, we aimed to determine if levels of...

OBJECTIVEThis study aimed to investigate the association between continuous glucose monitoring (CGM)-derived glycemic...

OBJECTIVEIn November 2022, teplizumab-mzwv became the first drug approved to delay the onset of stage 3 type 1 diabetes in...

OBJECTIVETo investigate gastrointestinal infection episodes (GIEs) in relation to the appearance of islet autoantibodies in...

This study was funded internally through an agreement between ICES and Women’s College Hospital.

In Table 2 of the article cited above, there were typographical errors in the presentation of triglycerides and non-HDL...